Navigation Links
Pharmaceutical Giants Back Researchers in Unique US Competition
Date:9/9/2013

LONDON, September 9, 2013 /PRNewswire/ --

Record numbers of global pharmaceutical companies and CROs, including Abbvie, GSK, Lilly, Covance, ICON, INC Research, inVentiv Health Clinical, PAREXEL, PPD and PRA International, have entered this year's US Clinical Researcher of the Year, organized by pharmaceutical media company PharmaTimes.

"This year's record entry is a result of the outstanding collaborative effort of the leading pharma companies and sponsoring CROs on the competition's executive steering committee and partnerships developed with ACRP, CenterWatch and the Society of Clinical Research Sites, which have helped to promote engagement with their communities," says steering group chair Sean Morgan-Jones.

Unique awards

The US Clinical Researcher of the Year competition is a unique competency-based program that invites researchers to compete head to head in a real-life challenge devised by US clinical directors from companies including GSK, Sanofi, AZ, Alcon, Shire, MSD and Endo Pharmaceuticals. "This is a fantastic opportunity for clinical research to showcase their most talented people," says Carol Parish, senior director, clinical development, head EU and EMAP, Stiefel, a GSK company.

The finals day will take place on the 7 November, 2013, at the spectacular global headquarters of finals hosts SAS in Cary, North Carolina. This year, special workshops have been organized for the finalists and guests to provide additional development opportunities and will span areas including the use of social media to assist patient recruitment and engagement.

Prestigious awards ceremony

The evening of the 7 November will see global pharma industry representatives come together at the prestigious Umsted Hotel, Cary, North Carolina, to hear the winners being announced. "It will be an occasion to remember and put an important global spotlight, not just on talented individuals and teams who made the finals but also on the companies who they represent and the whole clinical research fraternity," adds Sean Morgan-Jones.

Limited opportunities are available for sponsorship and a few tickets still remain. To book tickets go to http://www.usclinicalresearcher.com/book-now or to discuss sponsorship opportunities, contact Donna Lee Randall on +44(0)20-8487-9105 or donna@pharmatimes.com.

With thanks to our sponsors CORE, INC Research, inVentiv Health Clinical, PRA International and SAS, and to our executive steering group, with senior representatives from ACRP, APCR, Alcon, AstraZeneca, CenterWatch, Endo Pharmaceuticals, GSK, MSD, Shire, Sanofi and Steifel.


'/>"/>
SOURCE US Clinical Researcher of the Year
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Several Market Access Drivers Provide Attractive Opportunities for Multinational Companies in Saudi Arabias Pharmaceutical Market
2. DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals Establish Clinical Advisory Board in China
3. Sunshine Act 2013 Updates: A Checklist for Pharmaceutical Companies to Meet CMS Reporting
4. Biogen Idec and Isis Pharmaceuticals Announce Strategic Collaboration to Advance Treatment of Neurological Disorders
5. Altaire Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 9 lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution sold under several brands
6. SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Astex Pharmaceuticals, Inc.
7. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt
8. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference
9. 2013 Pharmaceutical Intellectual Property Forum is Coming in November
10. Buyout Alert -- Astex Pharmaceuticals -- Law Firm Seeks Higher Price For Shareholders
11. Auxilium Pharmaceuticals, Inc. To Present At The Stifel Nicolaus Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):